Michael Phillips
Michael Phillips is Director, Next Generation Bioprocessing R&D, at Merck. The life science business of Merck operates as MilliporeSigma in the US and Canada.
The Connected Process
January 2, 2018
Connecting processes can be considered the next stage in evolution for biopharma manufacture, but how should companies approach the challenges?
1 min read
The Connected Process-MS
January 3, 2018
Connecting processes can be considered the next stage in evolution for biopharma manufacture, but how should companies approach the challenges?
1 min read
Next-Generation Bioprocessing and the Implications for Viral Safety
November 18, 2019
With many companies embracing the move to next generation bioprocessing, it is important that they do not forget to re-examine their approach to viral safety.
1 min read
Next-Generation Bioprocessing and the Implications for Viral Safety
November 18, 2019
With many companies embracing the move to next generation bioprocessing, it is important that they do not forget to re-examine their approach to viral safety.
1 min read
Newsletters
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
